Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency

Files

Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11 beta-Hydroxysteroid Dehydrogenase Type 2 Deficiency.pdf (3.5 MB)

Date

2018

Type:

Article

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

161

Vistas totales

0
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

https://doi.org/10.1093/ajh/hpy051
 http://hdl.handle.net/11447/6100

item.page.extent

item.page.accessRights

item.page.other

item.page.references

Abstract

Background: Pathogenic variations in HSD11B2 gene triggers the apparent mineralocorticoid excess syndrome (AME). There is scarce information regarding the phenotypes of subjects carrying heterozygous ...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Carvajal CA, Tapia-Castillo A, Valdivia CP, Allende F, Solari S, Lagos CF, Campino C, Martínez-Aguayo A, Vecchiola A, Pinochet C, Godoy C, Iturrieta V, Baudrand R, Fardella CE. Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency. Am J Hypertens. 2018 Jul 16;31(8):910-918. doi: 10.1093/ajh/hpy051

Keywords

11βHSD2 deficiency , AME syndrome , Blood pressure , Cortisol , Cortisone , HSD11B2 mutation , Hypertension

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026

Implementado por OpenGeek Services